Hematology Frontier

In 2024, the field of chronic myeloid leukemia (CML) witnessed significant breakthroughs in research and clinical advancements. From the development of novel therapeutic agents to the optimization of treatment strategies, from studies on treatment discontinuation to deeper explorations into disease mechanisms, these findings have expanded treatment options and brought new hope to patients. As we step into the new year, Hematology Frontier has invited Dr. Qian Jiang from Peking University People's Hospital to review the key research progress in CML over the past year, particularly focusing on breakthrough findings presented at the ASH and EHA Annual Meetings. Additionally, Jiang shares insights from her team’s clinical experience in CML management and offers a perspective on future directions, aiming to provide new insights for clinical practice and long-term patient care strategies.

In recent years, the field of hematologic malignancies has witnessed remarkable breakthroughs, with Chinese researchers making increasingly significant contributions, particularly in cellular therapy. Their work has played a crucial role in advancing both scientific progress and clinical practice. As we step into the new year, Hematology Frontier has invited Dr. Huilai Zhang from Tianjin Medical University Cancer Institute and Hospital to provide an in-depth review of the current landscape and key developments in follicular lymphoma in 2024. This comprehensive analysis aims to offer valuable insights for clinical practice and future research directions.

Editor's Note: In recent years, the treatment landscape for newly diagnosed multiple myeloma (MM) has seen numerous innovations and breakthroughs. However, these advancements have also brought new complexities and challenges.…

As we step into 2025, we reflect on the incredible progress made in hematology and set our sights on the breakthroughs to come. This heartfelt message celebrates the dedication of our doctors, researchers, and patients who inspire hope and innovation every day. Let’s work hand in hand to bring new solutions, brighter outcomes, and life-changing treatments to patients worldwide. Together, we can push the boundaries of medicine and create miracles in hematology. Watch this inspiring New Year message as we welcome a year of health, happiness, and progress. Let’s embrace 2025 with hope and determination!

The 66th Annual Meeting of the American Society of Hematology (ASH), the largest global academic event in the field of hematology, took place from December 7 to 10, 2024, in San Diego, USA. The event brought  together leading researchers and clinicians from around the world to discuss cutting-edge advancements in hematology, innovative therapies, and ongoing clinical trials.Following rigorous peer review, 10 high-quality abstracts from the Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences were selected for oral presentations, and an additional 83 abstracts were featured in poster sessions.

Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) in 2024 concluded successfully, gathering over 30,000 experts and scholars from around the world. Through meticulously planned…

Editor's Note: From December 7 to 10, 2024, the 66th Annual Meeting of the American Society of Hematology (ASH) was held in San Diego, bringing together global experts in hematology…

Editor's Note: The 66th Annual Meeting of the American Society of Hematology (ASH) successfully concluded in 2024, bringing together over 30,000 experts and scholars from around the world. With over…

From December 7 to 10, 2024, the 66th Annual Meeting of the American Society of Hematology (ASH) convened in San Diego, attracting global hematology experts to discuss groundbreaking research. During…